[Corticoid myopathy in children].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001171:Arthritis, Juvenile / Q000188:drug therapy; D002648:Child; D003692:Delayed-Action Preparations; D003907:Dexamethasone / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008297:Male; D009135:Muscular Diseases / Q000139:chemically induced*; D009404:Nephrotic Syndrome / Q000188:drug therapy; D011239:Prednisolone / Q000009:adverse effects* / Q000627:therapeutic use
D003692:Delayed-Action Preparations; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone
Beitrag zur Kortikoidmyopathie im Kindesalter.